Abstract
OBJECTIVE: Identify characteristics of Kentucky community pharmacists and community pharmacists' practice environment associated with utilization of the Kentucky All Schedule Prescription Electronic Reporting Program (KASPER).
METHODS: Surveys were mailed to all 1,018 Kentucky pharmacists with a KASPER account and an additional 1,000 licensed pharmacists without an account. Bivariate analyses examined the association between KASPER utilization and practice type (independent or chain) and practice location (rural or urban). A multivariate Poisson regression model with robust error variance estimated risk ratios (RR) of KASPER utilization by characteristics of pharmacists' practice environment.
RESULTS: Responses were received from 563 pharmacists (response rate 27.9%). Of these, 402 responses from community pharmacists were included in the analyses. A majority of responding pharmacists (84%) indicated they or someone in their pharmacy had requested a patient's controlled substance history since KASPER's inception. Bivariate results showed that pharmacists who practiced in independent pharmacies reported greater KASPER utilization (94%) than pharmacists in chain pharmacies (75%; p
CONCLUSION: Utilization of KASPER differs by community pharmacists' practice environment, predominantly by practice type and location. Understanding characteristics of community pharmacists and community pharmacists' practice environment associated with PDMP use is necessary to remove barriers to access and increase utilization thereby increasing PDMP effectiveness.
Document Type
Article
Publication Date
4-2015
Funding Information
The Kentucky Cabinet for Health and Family Services, Office of the Inspector General.
Repository Citation
Wixson, Sarah E.; Blumenschein, Karen; Goodin, Amie J.; Talbert, Jeffery; and Freeman, Patricia R., "Prescription Drug Monitoring Program Utilization in Kentucky Community Pharmacies" (2015). Pharmacy Practice and Science Faculty Publications. 16.
https://uknowledge.uky.edu/pps_facpub/16
Notes/Citation Information
Published in Pharmacy Practice, v. 13, no. 2, article 540, p. 1-6.
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.